In vitro antiviral activity of bael (Aegle marmelos Corr) upon human coxsackieviruses B1-B6

Journal of Communicable Diseases

Volumn 34, Issue 2, 2002, Pages 88-99

  Badam, Lalita ^a   Bedekar, S S ^a   Sonawane, Kiran B ^b   Joshi, Swati P ^b  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; RIBAVIRIN; COUMARIN DERIVATIVE; FURAN DERIVATIVE; PENTOSALEN; PLANT MEDICINAL PRODUCT;

ADSORPTION; ANTIVIRAL ACTIVITY; ARTICLE; COXSACKIE VIRUS B; CYTOTOXICITY; DRUG EFFICACY; FRUIT (STRUCTURE); GROWTH CURVE; HOST CELL; IC 50; NONHUMAN; PLANT LEAF; VERO CELL; VIROGENESIS; VIRUS CULTURE; VIRUS INACTIVATION; VIRUS REPLICATION; AEGLE; CHEMISTRY; DRUG EFFECT; ENTEROVIRUS; HUMAN; ISOLATION AND PURIFICATION;

AEGLE; ANTIVIRAL AGENTS; COUMARINS; ENTEROVIRUS B, HUMAN; FURANS; HUMANS; PLANT PREPARATIONS; RIBAVIRIN;

EID: 1542740457     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Dalldorf G and Melnick JL. Coxsackieviruses. In: Horsfall FL. JR, Tamm I eds. Viral and rickettsial infections of man. 4th ed. Philadelphia JB Lippincott, 1965; 74: 512.
2. Ikeda RM, Kondracki SF, Drabkin PD, Birkhead GS and Morse. Pleurodynia among football players at a high school: An outbreak associated with coxsackie virus B1. JAMA 1993; 270: 2205-2206.
3. Alexander JP Jr, Chapman LE, Pallansch MA, Stephenson WT, Torak TJ and Anderson LJ. Coxsackievirus B2 Infection and asceptic meningitis; a focal outbreak among members of a high school football team. J Infect Dis 1993; 167: 1201-1205.
4. Badam L and Thakre JP. Detection of coxsackievirus B-4 antibodies in cases of suspected encephalopathy by microneutralization test. J Commun Dis 2001; 33(2): 78-82.
5. Berlin LE, Rorabaugh ML, Heldrich F, Roberts K, Doran T and Modlin JF. Asceptic meningitis in infants <2 years of age' diagnosis and etiology. J Infect Dis 1993; 168: 888-892.
6. Moore M, Baron RC and Filstein MR. Asceptic meningitis and high school football players 1978-1980. JAMA 1983; 249: 2039-2042.
7. Bowles NE, Oslen EGJ, Richardson PJ and Archard LC. Detection of coxsackie B virus specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiopathy. Lancet 1985; 1: 1120-1123.
8. Burch GE, Sun SC, Ch KC, Sohal RS and Colcolough HL. Interstitial and Coxsackievirus B Myocarditis in infants and children: a Comparative histologic and immunofluorescent study of 50 autopsied hearts. Jama 1968; 203: 1-8.
9. Burch GE, Shewey LL and Harb JM. Coxsackie B-4 Viruses and atrial myxoma. Am Heart J 1974; 88: 634-639.
10. Kandolf R and Hofschneider PH. Molecular cloning of the genome of a cardiotropic Coxsackie B 3 virus: full length reverse transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Nat A cad Sci 1985: USA; 82: 4818-4822.
11. Lau RCH. Coxsackie B virus infections in New Zealand patients with cardiac and non cardiac diseases. J Med Virol 1983; 11: 131-137.
12. Lerner AM. Coxsackievirus myocardiopathy. J Infect Dis 1969; 120: 496-499.
13. Bowles NE, Dubiwitz V, Sewry CA and Archard LC. Dermatomyositis, Polymyositis and coxsackie B-virus infection. Lancet 1987; 1: 1104-1107.
14. Banatwala JE. Insulin-dependent (Juvenile-onset type-1) diabetes mellitus: Coxsackie B viruses revisited. Prog Med Virol 1987; 34: 33-54.
15. Hartig PC, Madge GE and Webb SR. Diversity within a human isolate of Coxsackie B4: relationship to viral induced diabetes. J Med Virol 1983; 12: 23-30.
16. Lee YJ, Yang D, Shyur SD and Chiu NC. Nuerogenic diabetes inspidus in a child with fatal Coxsackie virus B1 encephalitis. J Paediatr Endocrinol Metab 1995; 8: 301-304.
17. Nakao T. Coxsackieviruses and diabetes. Lancet 1971; 2: 1423.
18. Orchard TJ, Atchison RW and Becker D. Coxsackie infection and diabetes. Lancet 1983; 2: 631.
19. Yousef GE, Bell EJ and Mann GF. Chronic enterovirus infection in patients with post viral fatigue syndrome. Lancet 1988; 1: 146-150.
20. Hruska J, Morrow P, Suffin S and Douglas R, Jr. In vitro inhibition of respiratory syncytial virus by ribavirin. Antimicrob. Agents Chemother 1982; 21: 125-130.
21. Huggins J, Robbins R and Canonico P. Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses and arenaviruses. Antimicrob. Agents Chemother 1984; 26: 476-480.
22. Lewinsohn DM, Bowden RA, Mattson D and Crawford SW. Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrob Agents Chemother 1996; 40: 2555-2557.
23. Murphy ME, Kariwa H, Mijutani T, Yoshimatsu K, Arikawa J and Takashima I. In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus. Arch Virol 2000; 145: 1571-1582.
24. Okada I, Matsumori A, Matoba Y, Tominaga M, Yamada T and Kawai C. Combination treatment with ribavirin and interferon for coxsackie B3 replication. J Lab Clin Med 1992; 120: 569-573.
25. Streeter D, Witkowski J, Khore P, Sidwell R, Bauer R, Robins R and Simon L. Mechanism of action of 1-b-D ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole), a new broad-spectrum antiviral agent. Proc Natl Acad Sci 1973; USA 70: 1174-1178.
26. Badam L, Joshi SP and Bedekar SS. In vitro antiviral activity of neem (Azadirachta indica A. Juss) leaf extract against group B coxsackieviruses. J Commun Dis 1999; 31: 79-90.
27. Badam L. Glycyrrhizin as an alternate drug for PCP in Aids patients. J Parasit Dis 2000b; 24(2) : 235.
28. Vanden Berghe DA, Vlietinck AJ and Van Hoof L. Plant products as potential antiviral agents. Bull Inst Pasteur 1986; 84: 101-147.
29. Aghnivesa, (1941) The Charak Samthita, Mumbai Nirnay Sagar Press, Mumbai, India.
30. Babbar OP, Joshi MN and Madan AR. Evaluation of plants for antiviral activity. Indian J Med Res 1932; 76: 54-65.
31. Badam L. 'In vitro' studies on the effect of glycyrrhizin from Indian Glycyrrhiza glabra on some RNA and DNA viruses. Indian J Pharmacol 1994; 26: 194-199.
32. Badam L. 'In vitro' studies on the effect of Acorus calamus extract and Beta Asarone on Herpes viruses. Deerghayu International 1995; 11: 16-18.
33. Badam L. 'In vitro' antiviral activity of indigenous glycyrrhizin, licorice and Glycyrrhizic acid (Sigma) on Japanese encephalitis virus. J Commun Dis 1997a; 29: 91-99.
34. Badam L. Ammonium salt of Glycyrrhizic acid as an antiviral. Nat Med J India 1997b; 10: 98.
35. Badam L. Eugenol as an antiviral. J Med Arom 2000a; Plants (In press).
36. Rastogi RP and Dhawan BN. Research on medicinal plants at the Central Drug Research Institute, Lucknow. Indian J Med Res 1982; 76: 27-45.
37. Satyawati GV, Raina MK and Sharma M. Medicinal plants of India ICMR New Delhi 1 1996 ; (I), 24-27.
38. Thyagrajan SP. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet 1988; II: 764-766.
39. Wealth of India (1985). Raw materials, Vol. 1, Revised Edition; Council of Scientific and Industrial Research New Delhi.
40. Das B and Das R. Medicinal properties and chemical constituents of Aegle marmelos Corr. Indian Drugs 1995; 32: 93-95.
41. Jain NK. Antifungal activity of essential oil of Aegle marmelos. Indian Drugs Pharma Ind 1997; 12: 55.
42. Murray RBH, Jorge ZD and Bog DM. Claisen rearrangements-XIV. Synthesis of coumarin, benchorin and revision of the structure of marmelide. Tetrahedron 1984; 40: 5225-5227.
43. Reed LJ and Muench HA. A Simple method of estimating fifty percent end points. Am J Hyg 1983; 27: 493-497.
44. Harvey SK. A preliminary communication of the action of Aegle mannelos (Bael) on heart. Indian J Med Res 1968; 56: 327-331.
45. Horwitz MS, La Cava A, Fine C, Rodriguiz E, Ilic A and Sarvetnick N. Pancreatic expression of interferon-r protects mice from lethal Coxsackievirus B3 infection and Subsequent myocarditis. Nature Medicine 2000; 6: 693-697.
46. Rose NR. Viral damage or Molecular nimicry-placing the blame in myocarditis. Nature Medicine 2000; 6: 631-632